Ponaxen 15mg (Ponatinib Tablet) 15mg

Ponaxen is a tyrosine kinase inhibitor used in the treatment of blood cancers. It is primarily indicated for the following conditions:

• Chronic Myeloid Leukemia (CML): Used to treat CML in patients who are resistant or intolerant to other treatments.
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Effective in treating Ph+ ALL, particularly in cases where other therapies have failed.
• Resistant Cancer Cases: Often prescribed when other tyrosine kinase inhibitors (TKIs) have proven ineffective.

• Ponatinib works by inhibiting the BCR-ABL tyrosine kinase, including the T315I mutation, and other related kinases. This action blocks proliferative signaling in malignant cells, thereby inhibiting the growth and division of cancer cells.

Ponaxen may cause various side effects, which can be categorized as follows:

Common Side Effects

• Fatigue: A common side effect that may affect daily activities.
• Headache: Mild to moderate headaches are frequently reported.
• Abdominal Pain: Discomfort or pain in the abdominal area.
• Nausea: A feeling of sickness that may or may not lead to vomiting.
• Diarrhea: Frequent, loose bowel movements.
• Muscle or Joint Pain: Discomfort or pain in the muscles or joints.

Serious or Rare Side Effects

• Blood Clots: Increased risk of forming blood clots, which can be life-threatening.
• Heart Problems: Potential for cardiovascular issues, including irregular heartbeats.
• Liver Toxicity: Possible damage to the liver, requiring regular monitoring.
• Severe Skin Reactions: Including severe rashes or skin irritation.

Ponaxen should be used with caution and under medical supervision. Important precautions include:

• Pregnancy: Not recommended during pregnancy due to potential risk to the fetus.
• Liver Monitoring: Regular liver function tests are necessary during treatment.
• Cardiovascular Risk: Ponatinib may increase the risk of blood clots and heart-related problems.
• Do not crush or chew: Take the tablet as a whole with water.
• Follow oncologist instructions strictly: Adhere to the prescribed dosage and schedule.
• Store below 25°C: Keep in the original pack, protect from moisture.

Ponaxen may interact with other medications, which can be categorized as follows:

Major Interactions (Avoid)

• Strong CYP3A4 Inducers: Such as rifampin, which can decrease the effectiveness of Ponatinib.
• Strong CYP3A4 Inhibitors: Such as ketoconazole, which can increase the risk of side effects.
• Drugs that Prolong QT Interval: Such as quinidine, which can increase the risk of heart problems.

Moderate Interactions (Monitor Closely)

• Anticoagulants: Such as warfarin, which may require dose adjustments.
• Antiplatelet Drugs: Such as aspirin, which may increase the risk of bleeding.
• Other Anticancer Drugs: Such as chemotherapy agents, which may enhance side effects.